½ÃÀ庸°í¼­
»óǰÄÚµå
1529948

ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Healthcare Asset Management Market Size, Share & Trends Analysis Report By Product (RFID, RTLS), By Application, By End Use (Hospitals, Laboratories, Others), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÃÀå ±Ô¸ð ¹× µ¿Çâ

¼¼°è ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀåÀº 2023³â 258¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 23.0% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾÷¹« È¿À²È­¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ÀǾàǰ À§Á¶ ÇàÀ§ Áõ°¡, ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

¶ÇÇÑ, ½ÃÀå ÁøÀÔ ±â¾÷µéÀº ÀÇ·á±â°üÀÇ ÀÚ»ê °ü¸®¸¦ Áö¿øÇϴ ÷´Ü ±â¼ú ¹× ¼Ö·ç¼ÇÀ» °³¹ßÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ÀÓ»ó ÀÚ»ê °ü¸® ±â¾÷ TRIMEDX´Â 2024³â 4¿ù¿¡ ÇコÄɾî ȯ°æÀ» À§ÇÑ Áö¿À¼¾½º(GeoSense)¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ç½Ã°£ À§Ä¡ ½Ã½ºÅÛ(RTLS)Àº ÀÇ·á ÀåºñÀÇ Á¤È®ÇÑ ÃßÀûÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾î ÀÇ·á ½Ã¼³ÀÇ ÀÚ»ê °ü¸®¸¦ ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ»ê °ü¸® ¼Ö·ç¼ÇÀº ÀÇ·á ½Ã½ºÅÛ¿¡¼­ Àåºñ °Ë»ö ½Ã°£ ´ÜÃà, ÀÓ»ó È¿À²¼º Çâ»ó, À¯Áöº¸¼ö ¹× ¼ö¸®¿Í °°Àº ÀÓ»ó ¿£Áö´Ï¾î¸µ ¼­ºñ½º °³¼±, ¼­ºñ½º Á¦°ø °³¼±, Àç°í °ü¸® °­È­, Àåºñ °¡¿ë¼º Çâ»ó µî ¿©·¯ °¡Áö ¸ñÀûÀ» ´Þ¼ºÇÕ´Ï´Ù. ÀÚ»ê °ü¸® ¼Ö·ç¼ÇÀÌ Á¦°øÇÏ´Â ÀÌ·¯ÇÑ ÀåÁ¡Àº ÀÇ·á ½Ã½ºÅÛ¿¡¼­ Àα⸦ ³ôÀÌ°í ¼¼°è ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¦¾àȸ»çµéÀÌ Á¦¾à »ê¾÷À» °Ü³ÉÇÑ ¼Ö·ç¼ÇÀÇ °³¹ß°ú ÇÔ²² ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ´Ã¸®°í Àֱ⠶§¹®¿¡ ÀÌ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀº º´¿ø°ú Áø·á¼Òº¸´Ù ´õ ±¤¹üÀ§ÇÏ°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¾ÆÀÌÁ¸Àº Áö³­ 1¿ù Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷À» À§ÇØ ¼³°èµÈ ÀÚ»ê ¸ð´ÏÅ͸µ ¾ÖÇø®ÄÉÀ̼ÇÀÎ '¾ÆÀÌÁ¸ ¿¡¼Â Çコ(Aizon Asset Health)'¸¦ Ãâ½ÃÇØ Áö´ÉÇü À¯Áöº¸¼ö ÀÌ·Â ºÐ¼®, Áß¿ä ÀÚ»êÀÇ »óÅ ¸ð´ÏÅ͸µ, ÀáÀçÀû ¹®Á¦ ½Äº°À» ÅëÇØ Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷ÀÌ °èȹµÇÁö ¾ÊÀº ´Ù¿îŸÀÓÀ» ¾ø¾Ö°í °èȹµÇÁö ¾ÊÀº ´Ù¿îŸÀÓÀ» ¾ø¾Ö°í À¯Áöº¸¼ö ºñ¿ëÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¼¼°è °¢±¹ Á¤ºÎ¿Í ¹Î°£ ±â°üÀº ÇコÄÉ¾î ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ °­È­Çϰí ÀÖÀ¸¸ç, ÇコÄɾî ÀÎÇÁ¶ó ±¸Ãà¿¡ ´ëÇÑ ÅõÀÚ°¡ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, »ç¿ìµð¾Æ¶óºñ¾Æ´Â 2023³â ÀÇ·á ºÐ¾ß¿¡ 504¾ï ´Þ·¯¸¦ ÁöÃâÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ¶ÇÇÑ »ç¿ìµð´Â ÀÇ·á ÀÎÇÁ¶ó ±¸ÃàÀ» À§ÇØ ¾à 650¾ï ´Þ·¯ÀÇ ÅõÀÚ¸¦ ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ Àü ¼¼°èÀûÀ¸·Î ÅõÀÚ°¡ È®´ëµÇ°í ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇÔ¿¡ µû¶ó ÀÇ·á ½Ã¼³ÀÇ ¿î¿µ È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ´Â ±â¼ú ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÇ·á ÀÚ»ê °ü¸® ¼Ö·ç¼ÇÀÇ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
  • ¾÷°è ºÐ¼®
    • »ç¿ëÀÚÀÇ °üÁ¡ ºÐ¼®
    • ÁÖ¿ä ÃÖÁ¾ ¿ëµµ
  • Å×Å©³î·¯Áö Àü¸Á
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ¾÷°è °úÁ¦¿Í ±âȸ ºÐ¼®
  • ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå ºÐ¼® Åø
    • Porters ºÐ¼®
    • PESTEL ºÐ¼®
  • ÇコÄɾî ÀÚ»ê °ü¸® ¾÷°èÀÇ ÁÖ¿ä °Å·¡¿Í Àü·«Àû Á¦ÈÞ ºÐ¼®
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • Á¦Ç° ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : Á¦Ç°º°, 2018-2030³â
  • ¹«¼±Á֯ļö ½Äº° Àåºñ(RFID)
  • ¾×¼¼¼­¸® Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º
  • ½Ç½Ã°£ À§Ä¡ÃßÀû ½Ã½ºÅÛ
  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦5Àå ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : ¿ëµµº°, 2018-2030³â
  • º´¿ø ÀÚ»ê °ü¸®
  • ÀǾàǰ ÀÚ»ê °ü¸®

Á¦6Àå ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ¿¹Ãø°ú µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • º´¿ø
  • ¿¬±¸¼Ò
  • ±âŸ

Á¦7Àå ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå : ±¹°¡, Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ª ½ÃÀå ÇöȲ
  • SWOT ºÐ¼®
  • ÇコÄɾî ÀÚ»ê °ü¸® ½ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â ¹× 2030³â, 10¾ï ´Þ·¯
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï »óȲ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ È÷Æ®¸Ê ºÐ¼®
  • Àü·« ¸ÅÇÎ
    • È®´ë
    • ÀμöÇÕº´
    • ÆÄÆ®³Ê½Ê°ú Çù¾÷
    • ½ÅÁ¦Ç° ¹ß¸Å
    • ¿¬±¸°³¹ß
  • ±â¾÷ °³¿ä
    • AiRISTA Flow, Inc.
    • CenTrak Inc.
    • Novanta Inc.
    • Sonitor Technologies
    • VERSUS TECHNOLOGIES
    • STANLEY Healthcare
    • Zebra Technologies Corporation
    • GE Healthcare
    • IBM
    • Siemens Healthcare GmbH
    • Motorola Solutions, Inc.
    • Infor, Inc.
    • Accenture PLC
    • Sonitor Technologies Inc.
    • Tyco International Ltd
ksm 24.08.29

Market Size & Trends

The global healthcare asset management market was estimated at USD 25.8 billion in 2023 and it is anticipated to grow at a CAGR of 23.0% from 2024 to 2030. The increasing need to enhance operational efficiency, rising drug counterfeiting activities, technological advancements, and growing healthcare expenditure are key drivers of market growth.

Moreover, the market players are developing advanced technologies and solutions to assist healthcare organizations in asset management, which is further expected to propel the market growth. For instance, in April 2024, TRIMEDX, a clinical asset management company, launched GeoSense for healthcare environments. This real-time location system (RTLS) is designed to offer precise tracking for medical devices, which can help medical facilities optimize their asset management.

Asset management solutions serve several purposes in the healthcare systems, such as reducing device search times, improving clinical efficiency, improving clinical engineering services such as maintenance and repairs, improving service delivery, enhancing inventory management, and improving device availability. These advantages offered by asset management solutions are increasing their popularity in the healthcare system, driving their demand globally.

Moreover, the adoption of this solution is wider than hospitals and clinics as pharmaceutical companies are increasingly adopting these solutions coupled with developing pharmaceutical industry targeted solutions. For instance, in January 2022, Aizon launched an asset monitoring application designed for pharmaceutical and biotech companies. The Aizon Asset Health offers intelligent historical maintenance analysis, critical assets condition monitoring, and identification of potential problems, which help the pharma and biotech companies to eliminate unplanned downtime and optimize maintenance costs.

Governments and private institutions globally have increased their focus on the healthcare sector, leading to an increase in investment in the development of healthcare infrastructure globally. For instance, Saudi Arabia intended to spend 50.4 billion USD in its healthcare sector in 2023. Moreover, the county aims to invest around 65 billion USD for the development of the healthcare infrastructure. This growing investment and developing healthcare infrastructure globally increases the need for technological solutions to increase the operational efficiencies of healthcare facilities, which is expected to drive the demand for healthcare asset management solutions.

Global Healthcare Asset Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global healthcare asset management market report based on product, application and region.

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Radiofrequency Identification Devices (RFID)
    • Tags
      • Passive Tags
        • Low Frequency
        • High Frequency
      • Ultra-high frequency
      • Readers/Interrogators
      • Antennas
    • Accessories Hardware
    • Software
    • Services
      • Real Time Location Systems (RTLS)
    • Hardware
      • Tags/Badges
      • Readers/Interrogators
    • Software
    • Services
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Hospital Asset Management
      • Equipment Tracking and Management
      • Patient Management
      • Temperature and Humidity Control
      • Staff Control
      • Infection Control and Hand Hygiene Compliance
    • Pharmaceutical Asset Management
      • Drug Anti-counterfeiting
      • Supply Chain Management
    • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
      • Hospitals
      • Laboratories
      • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Asset Management Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Use
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Increasing Drug-Counterfeiting Activities
      • 3.5.1.2. Need to increase operational efficiency
      • 3.5.1.3. Technological advancements
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. High Implementation cost
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Healthcare Asset Management Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape
  • 3.7. Major Deals & Strategic Alliances Analysis in the Healthcare Asset Management Industry
  • 3.8. Impact of COVID-19

Chapter 4. Healthcare Asset Management Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Healthcare Asset Management Market: By Product, 2018 to 2030
  • 4.5. Radiofrequency Identification Devices (RFID)
    • 4.5.1. Radiofrequency Identification Devices (RFID) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Tags
        • 4.5.1.1.1. Tags Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.5.1.1.2. Passive Tags
          • 4.5.1.1.2.1. Passive Tags Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
          • 4.5.1.1.2.2. Low Frequency
            • 4.5.1.1.2.2.1. Low Frequency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
          • 4.5.1.1.2.3. High Frequency
            • 4.5.1.1.2.3.1. High Frequency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
          • 4.5.1.1.2.4. Ultra-High Frequency
            • 4.5.1.1.2.4.1. Ultra-High Frequency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.2. Readers/Interrogators
        • 4.5.1.2.1. Readers/Interrogators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Antennas
        • 4.5.1.3.1. Antennas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2. Accessories Hardware
      • 4.5.2.1. Accessories Hardware Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.3. Software
      • 4.5.3.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.4. Services
      • 4.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Real Time Location Systems (RTLS)
    • 4.6.1. Real Time Location Systems (RTLS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2. Hardware
      • 4.6.2.1. Hardware Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.2.2. Tags/Badges
        • 4.6.2.2.1. Tags/Badges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.2.3. Readers/Interrogators
        • 4.6.2.3.1. Readers/Interrogators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.3. Software
      • 4.6.3.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.4. Services
      • 4.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Healthcare Asset Management Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Delivery Mode Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Healthcare Asset Management Market: By Application, 2018 to 2030
  • 5.5. Hospital Asset Management
    • 5.5.1. Hospital Asset Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2. Equipment Tracking and Management
      • 5.5.2.1. Equipment Tracking and Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Patient Management
      • 5.5.3.1. Patient Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. Temperature and Humidity Control
      • 5.5.4.1. Temperature and Humidity Control Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.5. Staff Control
      • 5.5.5.1. Staff Control Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.6. Infection Control and Hand Hygiene Compliance
      • 5.5.6.1. Infection Control and Hand Hygiene Compliance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Pharmaceutical Asset Management
    • 5.6.1. Pharmaceutical Asset Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. Drug Anti-counterfeiting
      • 5.6.2.1. Drug Anti-counterfeiting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. Supply Chain Management
      • 5.6.3.1. Supply Chain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Healthcare Asset Management Market: End Use Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Healthcare Asset Management Market: By End Use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Laboratories
    • 6.6.1. Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Healthcare Asset Management Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use

  • 7.1. Definition and Scope
  • 7.2. Regional Market Share Analysis, 2023 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot
  • 7.5. SWOT Analysis
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Healthcare Asset Management Market Share, By Region, 2023 & 2030, USD Billion
  • 7.7. North America
    • 7.7.1. North America Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. U.S. Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Canada
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Canada Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.4. Mexico
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Mexico Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. Europe
    • 7.8.1. Europe Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. UK
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. UK Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Germany
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Germany Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. France
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. France Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Italy
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Italy Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.6. Spain
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.6.3. Competitive Insights
      • 7.8.6.4. Spain Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.7. Denmark
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.7.3. Competitive Insights
      • 7.8.7.4. Denmark Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.8. Sweden
      • 7.8.8.1. Key Country Dynamics
      • 7.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.8.3. Competitive Insights
      • 7.8.8.4. Sweden Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.9. Norway
      • 7.8.9.1. Key Country Dynamics
      • 7.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.9.3. Competitive Insights
      • 7.8.9.4. Norway Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.2. China
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.2.3. Competitive Insights
      • 7.9.2.4. China Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.3. Japan
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.3.3. Competitive Insights
      • 7.9.3.4. Japan Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.4. India
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.4.3. Competitive Insights
      • 7.9.4.4. India Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.5. South Korea
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.5.3. Competitive Insights
      • 7.9.5.4. South Korea Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.6. Australia
      • 7.9.6.1. Key Country Dynamics
      • 7.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.6.3. Competitive Insights
      • 7.9.6.4. Australia Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.7. Thailand
      • 7.9.7.1. Key Country Dynamics
      • 7.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.7.3. Competitive Insights
      • 7.9.7.4. Thailand Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.10. Latin America
    • 7.10.1. Latin America Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.10.2. Brazil
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.2.3. Competitive Insights
      • 7.10.2.4. Brazil Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.10.3. Argentina
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.3.3. Competitive Insights
      • 7.10.3.4. Argentina Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.11. Middle East and Africa
    • 7.11.1. Middle East and Africa Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Key Country Dynamics
      • 7.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.2.3. Competitive Insights
      • 7.11.2.4. Saudi Arabia Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.3. UAE
      • 7.11.3.1. Key Country Dynamics
      • 7.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.3.3. Competitive Insights
      • 7.11.3.4. UAE Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.4. South Africa
      • 7.11.4.1. Key Country Dynamics
      • 7.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.4.3. Competitive Insights
      • 7.11.4.4. South Africa Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.5. Kuwait
      • 7.11.5.1. Key Country Dynamics
      • 7.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.5.3. Competitive Insights
      • 7.11.5.4. Kuwait Healthcare Asset Management Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. AiRISTA Flow, Inc.
      • 8.6.1.1. Participant's Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Recent Developments
    • 8.6.2. CenTrak Inc.
      • 8.6.2.1. Participant's Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Recent Developments
    • 8.6.3. Novanta Inc.
      • 8.6.3.1. Participant's Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Recent Developments
    • 8.6.4. Sonitor Technologies
      • 8.6.4.1. Participant's Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Recent Developments
    • 8.6.5. VERSUS TECHNOLOGIES
      • 8.6.5.1. Participant's Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Recent Developments
    • 8.6.6. STANLEY Healthcare
      • 8.6.6.1. Participant's Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Recent Developments
    • 8.6.7. Zebra Technologies Corporation
      • 8.6.7.1. Participant's Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Recent Developments
    • 8.6.8. GE Healthcare
      • 8.6.8.1. Participant's Overview
      • 8.6.8.2. Financial Performance
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Recent Developments
    • 8.6.9. IBM
      • 8.6.9.1. Participant's Overview
      • 8.6.9.2. Financial Performance
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Recent Developments
    • 8.6.10. Siemens Healthcare GmbH
      • 8.6.10.1. Participant's Overview
      • 8.6.10.2. Financial Performance
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Recent Developments
    • 8.6.11. Motorola Solutions, Inc.
      • 8.6.11.1. Participant's Overview
      • 8.6.11.2. Financial Performance
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Recent Developments
    • 8.6.12. Infor, Inc.
      • 8.6.12.1. Participant's Overview
      • 8.6.12.2. Financial Performance
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Recent Developments
    • 8.6.13. Accenture PLC
      • 8.6.13.1. Participant's Overview
      • 8.6.13.2. Financial Performance
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Recent Developments
    • 8.6.14. Sonitor Technologies Inc.
      • 8.6.14.1. Participant's Overview
      • 8.6.14.2. Financial Performance
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Recent Developments
    • 8.6.15. Tyco International Ltd
      • 8.6.15.1. Participant's Overview
      • 8.6.15.2. Financial Performance
      • 8.6.15.3. Product Benchmarking
      • 8.6.15.4. Recent Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦